Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,685 | 11,593 | 10,525 | -158 | -1,736 |
| Depreciation Amortization | 37 | 238 | 30 | 5 | 0 |
| Accounts receivable | 3,013 | -2,729 | -11,579 | 144 | 2,534 |
| Accounts payable and accrued liabilities | N/A | 361 | N/A | -59 | N/A |
| Other Working Capital | 1,673 | -10,948 | -15,966 | -3,846 | -777 |
| Other Operating Activity | -2,209 | 5,549 | 14,195 | 1,841 | -1,468 |
| Operating Cash Flow | $830 | $4,064 | $-2,794 | $-2,073 | $-1,447 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 7 | -303 | -303 | -59 | N/A |
| Investing Cash Flow | $7 | $-303 | $-303 | $-59 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 685 | 2,675 | 1,705 | 1,435 | 601 |
| Other Financing Activity | 0 | -70 | 0 | 0 | 0 |
| Financing Cash Flow | $685 | $2,605 | $1,705 | $1,435 | $601 |
| Exchange Rate Effect | -305 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 30,981 | 24,614 | 24,614 | 24,614 | 24,614 |
| End Cash Position | 32,198 | 30,981 | 23,222 | 23,917 | 23,768 |
| Net Cash Flow | $1,217 | $6,367 | $-1,392 | $-697 | $-845 |
| Free Cash Flow | |||||
| Operating Cash Flow | 830 | 4,064 | -2,794 | -2,073 | -1,447 |
| Capital Expenditure | N/A | -303 | -303 | -59 | N/A |
| Free Cash Flow | 830 | 3,761 | -3,097 | -2,132 | -1,447 |